Reverse Transcriptase Market By Type ( M-MLV Reverse Transcriptase, AMV Reverse Transcriptase ), By Application ( PCR, Sequencing, Cloning ), Industry Trends, Estimation & Forecast, 2017-2025

Check Today's Best Price

$3500 Buy Now
Reverse Transcriptase Market is expected to grow with a CAGR of XX% during the forecast period of 2018 to 2025.
  • Market Overview:

    Reverse transcriptase is a molecular enzyme that aids in the generation of complementary DNA from a RNA template during the process of reverse transcription. Advancements in technology has enabled the scientists to deeply study few reverse transcriptase enzymes such as HIV-1 reverse transcriptase, M-MLV reverse transcriptase, AMV reverse transcriptase, and Telomerase reverse transcriptase. The global reverse transcriptase market is witnessing a notable growth due to its surging applications in formulation of antiviral drugs, insulin production, and reverse transcription polymerase chain reaction among few others.

    The application of reverse transcriptase enzyme, which is also known as RNA-directed DNA polymerase, in the RT-PCR technique is mainly related to the diagnosis of cancerous diseases. Thus, the increasing incidences of cancerous diseases in the world, along with the surging demand for insulin among the diabetic patients are anticipated to fuel the growth of reverse transcriptase market around the globe. In terms of region, Asia-Pacific and North America are expected to offer lucrative opportunities to the market players during the upcoming years.

    The report provides detailed qualitative and quantitative analysis of the reverse transcriptase market. Market size and forecast in terms of value and volume has been provided for the period – (2017-2025), for the segments namely type, and application in each of the major regions.

    Reverse Transcriptase Market Segmentation

    By Type
    • M-MLV Reverse Transcriptase
    • AMV Reverse Transcriptase
    • Others

    By Application
    • PCR
    • Sequencing
    • Cloning
    • Others

    By Geography

    • North America
    o U.S.
    o Canada
    o Mexico

    • Europe
    o U.K.
    o France
    o Germany
    o Italy
    o Spain
    o Rest of Europe

    • Asia-Pacific
    o China
    o Japan
    o India
    o Korea
    o Rest of APAC

     • South America
    o Brazil
    o Rest of South America

    • Rest of the World
    o Middle East
    o Africa

    keyboard_arrow_up
  • CHAPTER 1. INTRODUCTION
    1.1. RESEARCH METHODOLOGY
    1.1.1. ERC desk research
    1.1.2. ERC data synthesis
    1.1.3. Data validation and market feedback
    1.1.4. ERC data sources

    CHAPTER 2. REVERSE TRANSCRIPTASE MARKET OVERVIEW
    2.1. REVERSE TRANSCRIPTASE MARKET INTRODUCTION
    2.2. GLOBAL REVERSE TRANSCRIPTASE MARKET PRODUCTION AND GROWTH RATE, 2017-2025
    2.2.1. Global Reverse Transcriptase Production (VOLUME) and Growth Rate (%), (2017-2025)
    2.3. GLOBAL REVERSE TRANSCRIPTASE MARKET CAPACITY AND GROWTH RATE, 2017-2025
    2.3.1. Global Reverse Transcriptase Capacity (VOLUME) and Growth Rate (%), (2017-2025)
    2.4. GLOBAL REVERSE TRANSCRIPTASE MARKET REVENUE AND GROWTH RATE, 2017-2025
    2.4.1. Global Reverse Transcriptase Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
    2.5. GLOBAL REVERSE TRANSCRIPTASE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
    2.5.1. Global Reverse Transcriptase Consumption (VOLUME) and Growth Rate (%), (2017-2025)
    2.6. GLOBAL REVERSE TRANSCRIPTASE MARKET PRICE TREND, 2017-2025
    2.6.1. Global Reverse Transcriptase Market Price Trend and Growth Rate (%), (2017-2025)

    CHAPTER 3. GLOBAL REVERSE TRANSCRIPTASE MARKET BY TYPE, 2017-2025
    3.1. M-MLV REVERSE TRANSCRIPTASE
    3.2. AMV REVERSE TRANSCRIPTASE
    3.3. OTHERS
    3.4. GLOBAL REVERSE TRANSCRIPTASE MARKET REVENUE BY TYPE, 2017-2025
    3.4.1. Global Reverse Transcriptase Market Revenue (Million USD) and Share (%) By Type, 2017-2025
    3.4.2. M-MLV Reverse Transcriptase Market Revenue and Growth Rate, 2017-2025
    3.4.3. AMV Reverse Transcriptase Market Revenue and Growth Rate, 2017-2025
    3.4.4. Others Market Revenue and Growth Rate, 2017-2025
    3.5. GLOBAL REVERSE TRANSCRIPTASE MARKET PRODUCTION BY TYPE, 2017-2025
    3.5.1. Global Reverse Transcriptase Market Production (Volume) and Share (%) By Type, 2017-2025
    3.5.2. M-MLV Reverse Transcriptase Market Production and Growth Rate, 2017-2025
    3.5.3. AMV Reverse Transcriptase Market Production and Growth Rate, 2017-2025
    3.5.4. Others Market Production and Growth Rate, 2017-2025

    CHAPTER 4. GLOBAL REVERSE TRANSCRIPTASE MARKET BY APPLICATION, 2017-2025
    4.1. PCR
    4.2. SEQUENCING
    4.3. CLONING
    4.4. GLOBAL REVERSE TRANSCRIPTASE MARKET REVENUE BY APPLICATION, 2017-2025
    4.4.1. Global Reverse Transcriptase Market Revenue (Million USD) and Share (%) By Application, 2017-2025
    4.4.2. PCR Market Revenue and Growth Rate, 2017-2025
    4.4.3. Sequencing Market Revenue and Growth Rate, 2017-2025
    4.4.4. Cloning Market Revenue and Growth Rate, 2017-2025
    4.5. GLOBAL REVERSE TRANSCRIPTASE MARKET CONSUMPTION BY APPLICATION, 2017-2025
    4.5.1. Global Reverse Transcriptase Market Consumption (Volume) and share (%) By Application, 2017-2025
    4.5.2. PCR Market Consumption and Growth Rate, 2017-2025
    4.5.3. Sequencing Market Consumption and Growth Rate, 2017-2025
    4.5.4. Cloning Market Consumption and Growth Rate, 2017-2025

    CHAPTER 5. GLOBAL REVERSE TRANSCRIPTASE MARKET BY REGION, 2017-2025
    5.1. NORTH AMERICA
    5.1.1. U.S.
    5.1.2. Canada
    5.1.3. Mexico
    5.2. EUROPE
    5.2.1. U.K.
    5.2.2. France
    5.2.3. Germany
    5.2.4. Italy
    5.2.5. Spain
    5.2.6. Rest of Europe
    5.3. ASIA PACIFIC
    5.3.1. China
    5.3.2. Japan
    5.3.3. India
    5.3.4. Korea
    5.3.5. Rest of APAC
    5.4. SOUTH AMERICA
    5.4.1. Brazil
    5.4.2. Rest of South America
    5.5. REST OF THE WORLD
    5.5.1. Middle East
    5.5.2. Africa
    5.6. GLOBAL REVERSE TRANSCRIPTASE MARKET REVENUE BY REGION, 2017-2025
    5.6.1. Global Reverse Transcriptase Market Revenue (Million USD) and Share (%) By Region, 2017-2025
    5.6.2. North America Market Revenue and Growth Rate, 2017-2025
    5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
    5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
    5.6.5. South America Market Revenue and Growth Rate, 2017-2025
    5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025

    CHAPTER 6. GLOBAL REVERSE TRANSCRIPTASE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
    6.1. GLOBAL REVERSE TRANSCRIPTASE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
    6.1.1. Global Reverse Transcriptase Market Production (Volume) and Share (%) By Region, 2017-2025
    6.1.2. Global Reverse Transcriptase Market Consumption (Volume) and Share (%) By Region, 2017-2025
    6.1.3. North America Market Production and Consumption, 2017-2025
    6.1.4. Europe Market Production and Consumption, 2017-2025
    6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
    6.1.6. South America Market Production and Consumption, 2017-2025
    6.1.7. Rest of the World Market Production and Consumption, 2017-2025

    CHAPTER 7. MARKET DETERMINANTS
    7.1. MARKET DRIVERS
    7.2. MARKET RESTRAINTS
    7.3. MARKET OPPORTUNITIES
    7.4. MARKET DETERMINANTS RADAR CHART

    CHAPTER 8. GLOBAL REVERSE TRANSCRIPTASE MARKET COMPETITION BY MANUFACTURERS
    8.1. GLOBAL REVERSE TRANSCRIPTASE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
    8.1.1. Global Reverse Transcriptase Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
    8.2. GLOBAL REVERSE TRANSCRIPTASE REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
    8.2.1. Global Reverse Transcriptase Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
    8.3. REVERSE TRANSCRIPTASE MARKET COMPETITIVE SITUATION AND TRENDS
    8.3.1. Reverse Transcriptase Market Share (%) of Top 3 Manufacturers
    8.3.2. Reverse Transcriptase Market Share (%) of Top 5 Manufacturers

    CHAPTER 9. GLOBAL REVERSE TRANSCRIPTASE MANUFACTURERS ANALYSIS
    9.1. PROMEGA
    9.1.1. Business Overview
    9.1.2. Company Basic Information
    9.1.3. Reverse Transcriptase Product Details
    9.1.4. Promega Reverse Transcriptase Production, Revenue and Gross Margin
    9.2. FAPON BIOTECH
    9.2.1. Business Overview
    9.2.2. Company Basic Information
    9.2.3. Reverse Transcriptase Product Details
    9.2.4. Fapon Biotech Reverse Transcriptase Production, Revenue and Gross Margin
    9.3. TAKARA BIO INC.
    9.3.1. Business Overview
    9.3.2. Company Basic Information
    9.3.3. Reverse Transcriptase Product Details
    9.3.4. Takara Bio Inc. Reverse Transcriptase Production, Revenue and Gross Margin
    9.4. ROCHE
    9.4.1. Business Overview
    9.4.2. Company Basic Information
    9.4.3. Reverse Transcriptase Product Details
    9.4.4. Roche Reverse Transcriptase Production, Revenue and Gross Margin
    9.5. MERCK KGAA
    9.5.1. Business Overview
    9.5.2. Company Basic Information
    9.5.3. Reverse Transcriptase Product Details
    9.5.4. Merck KGaA Reverse Transcriptase Production, Revenue and Gross Margin
    9.6. AGILENT TECHNOLOGIES, INC.
    9.6.1. Business Overview
    9.6.2. Company Basic Information
    9.6.3. Reverse Transcriptase Product Details
    9.6.4. Agilent Technologies, Inc. Reverse Transcriptase Production, Revenue and Gross Margin
    9.7. VAZYME
    9.7.1. Business Overview
    9.7.2. Company Basic Information
    9.7.3. Reverse Transcriptase Product Details
    9.7.4. Vazyme Reverse Transcriptase Production, Revenue and Gross Margin
    9.8. QIAGEN N.V.
    9.8.1. Business Overview
    9.8.2. Company Basic Information
    9.8.3. Reverse Transcriptase Product Details
    9.8.4. QIAGEN N.V. Reverse Transcriptase Production, Revenue and Gross Margin
    9.9. HOFFMANN-LA ROCHE LTD
    9.9.1. Business Overview
    9.9.2. Company Basic Information
    9.9.3. Reverse Transcriptase Product Details
    9.9.4. Hoffmann-la Roche Ltd Reverse Transcriptase Production, Revenue and Gross Margin
    9.10. THERMO FISHER
    9.10.1. Business Overview
    9.10.2. Company Basic Information
    9.10.3. Reverse Transcriptase Product Details
    9.10.4. Thermo Fisher Reverse Transcriptase Production, Revenue and Gross Margin

    CHAPTER 10. REVERSE TRANSCRIPTASE MARKET VALUE CHAIN ANALYSIS
    10.1. REVERSE TRANSCRIPTASE INDUSTRIAL CHAIN ANALYSIS
    10.2. REVERSE TRANSCRIPTASE KEY RAW MATERIALS ANALYSIS
    10.2.1. Key Raw Materials
    10.2.2. Price Trend of Key Raw Materials
    10.2.3. Key Suppliers of Raw Materials
    10.3. CONSUMER ANALYSIS
    10.3.1. Consumer 1
    10.3.2. Consumer 2
    10.3.3. Consumer 3
    10.3.4. Consumer 4

    keyboard_arrow_up
  • • Promega
    • Fapon Biotech
    • Takara Bio Inc.
    • Roche
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Takara Bio
    • Vazyme
    • QIAGEN N.V.
    • Hoffmann-la Roche Ltd
    • Thermo Fisher
    • Bio-Rad
    • Toyobo
    • Illumina Inc.
    • New England Biolabs Inc.

    keyboard_arrow_up


    • Keep your personal detail safe with us. Privacy Policy
      This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

What Information does this report contain?

• What was the market size of the Reverse Transcriptase Market in 2017 and the expected market size by 2025, along with the growth rate?
• An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
• Which are the largest revenue generating products, services or regions, and their comparative growth rate?
• Which technology is on trend and how would it evolve during the forecast period (2017 – 2025)?
• Which are the leading companies in the Reverse Transcriptase Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

You may also like

CLIENTS

SHARE YOUR CART